Clinical Inquiries

What is the best way to manage GERD symptoms in the elderly?

Author and Disclosure Information

 

References

EVIDENCE-BASED ANSWER

No evidence supports one method over another in managing uncomplicated gastroesophageal reflux disease (GERD) for patients aged >65 years. For those with endoscopically documented esophagitis, proton pump inhibitors (PPIs) relieve symptoms faster than histamine H2 receptor antagonists (H2RAs) (strength of recommendation [SOR]: B, extrapolation from randomized controlled trials [RCTs]). Treating elderly patients with pantoprazole (Protonix) after resolution of acute esophagitis results in fewer relapses than with placebo (SOR: B, double-blind RCT). Limited evidence suggests that such maintenance therapy for prior esophagitis with either H2RAs or PPIs, at half- and full-dose strength,1 decreases the frequency of relapse (SOR: B, extrapolation from uncontrolled clinical trial).

Laparoscopic antireflux surgery for treating symptomatic GERD among elderly patients without paraesophageal hernia reduces esophageal acidity, with no apparent increase in postoperative morbidity or mortality compared with younger patients (SOR: C, nonequivalent before-after study). Upper endoscopy is recommended for elderly patients with alarm symptoms, new-onset GERD, or longstanding disease (SOR: C, expert consensus; see TABLE).

Elderly patients are at risk for more severe complications from GERD, and their relative discomfort from the disease process is often less than from comparable pathology for younger patients (SOR: C, expert consensus). Based on safety profiles and success in the general patient population, PPIs as a class are considered first-line treatment for GERD and esophagitis for the elderly (SOR: C, expert consensus).

CLINICAL COMMENTARY

Teasing out serious disease from routine GERD is a challenge in the elderly
Peter Danis, MD
St. John’s Mercy Medical Center, St. Louis, Mo

Who really needs the invasive workup and expensive medicine, and who needs the simple approach? Elderly patients can attribute symptoms to “just indigestion” when there are other more serious diseases present (ie, angina, severe esophagitis, stricture, cancer). The physician may need a more detailed and patient approach to get the “real” story. Lifestyle changes and over-the-counter medications will resolve the majority of GERD symptoms. If the simple things don’t work or there are warning signs/symptoms, then a further workup is needed. The older patient may then be willing to pay the cost of the long term PPI when they know that there is significant pathology and the potential for long term symptom relief.

Evidence summary

Aggregated data from 2 randomized reflux esophagitis trials conducted in the United Kingdom were analyzed with respect to patient age. Comparison of symptom relief and esophageal lesion healing showed that elderly patients treated with omeprazole (Prilosec) fared better than those treated with either cimetidine (Tagamet) or ranitidine (Zantac).2 The pooled data involved 555 patients with endoscopically proven reflux esophagitis, 154 of whom were over the age of 65. After 8 weeks, rates of esophageal healing among the elderly were 70% for those receiving omeprazole and 29% for those receiving H2RAs (41% difference; 95% confidence interval [CI], 26–55), while the rate of asymptomatic elderly patients was 79% for the omeprazole group and 51% for the H2RA group (28% difference; 95% CI, 12–44).3 Patients treated with omeprazole healed faster than those taking H2RAs, as shown by endoscopy, and more of them experienced symptom relief.

A multicenter, randomized, double-blind trial of GERD maintenance therapy started with an initial open phase in which elderly patients with GERD and documented esophagitis were treated and then had documented resolution of esophagitis by endoscopy after 6 months. The researchers then randomized 105 of these elderly patients to receive treatment with either low-dose (20 mg/d) pantoprazole or placebo for 6 months. Endoscopy was performed after 12 months for all patients, unless indicated sooner. Intention-to-treat analysis showed a disease-free rate of 79.6% (95% CI, 68.3–90.9) in the treatment group, compared with 30.4% (95% CI, 18.3–42.4) in the placebo group (number needed to treat [NNT]=2). Symptom reports concerning the same patients also suggest a marked drop in symptoms that correlated with healing.4

A prospective, nonequivalence, before-after study compared efficacy of, and complications from, laparoscopic surgery for symptomatic GERD between younger and older (≥65 years) patients. The investigators examined postoperative morbidity and mortality for 359 patients referred for laparoscopic surgery, either a partial or Nissen (full) fundoplication. They excluded those requiring more extensive surgery or repair of paraesophageal hernia. The 42 elderly patients had a higher mean American Society of Anesthesiologists score compared with the younger patients, reflecting higher preoperative comorbidity, but were similar with regard to weight and gender.

Pages

Evidence-based answers from the Family Physicians Inquiries Network

Recommended Reading

Best Surveillance of Barrett's Takes an Overview
MDedge Family Medicine
Genetic Polymorphism Test Could Identify Barrett's Patients at Risk for Progression
MDedge Family Medicine
Novel PPI-NSAID Pill May Prevent GI Mucosal Injury
MDedge Family Medicine
Earlier Colorectal Screening Urged for Key Groups : African Americans, diabetics, and female smokers are found to be at substantially above-average risk.
MDedge Family Medicine
Colorectal Cancer Risk Not Tied To Dietary Fiber, Studies Show
MDedge Family Medicine
Family MDs Veer Off Constipation Guidelines More Than Pediatricians
MDedge Family Medicine
GI Profile Not Affected By COX Inhibitor Selectivity
MDedge Family Medicine
More Time May Be Needed for PPI Effects to Become Evident
MDedge Family Medicine
Data Reassuring on Gastro Complaints in Schoolchildren
MDedge Family Medicine
Pediatric GERD Safely Relieved by Half Adult Dose of Pantoprazole
MDedge Family Medicine